Steven Taylor

Aug 16, 2024 | nature.com | Sophie Miller |Steven Taylor |Andrew Shoubridge |Geraint B. Rogers

AbstractUrinary tract infections (UTI) are the most frequently diagnosed infection in residents of long-term care and are a major risk factor for urosepsis, hospitalisation, and death. Translocation of gut pathobionts into the urinary tract is the presumed cause of most UTIs. While specific gut microbiota characteristics have been linked to UTI risk in younger adults, their relevance in aged care residents remains uncertain.

May 14, 2024 | esmagazine.com | Steven Taylor

Many people don’t consider boilers to be a “green” technology. However, the truth is, steam is the ideal medium for moving heat around, and nothing else comes close. The bottom line is, steam is far greener than most people realize. The first thing to think about in regard to boilers and green technology is just how widespread its use is. Right now, boilers are a key part of the infrastructure to many of the world’s most important industries, which include about 80% of all products we use.

Apr 29, 2024 | esmagazine.com | Steven Taylor

Many people don’t consider boilers to be a “green” technology. However, the truth is, steam is the ideal medium for moving heat around, and nothing else comes close. The bottom line is, steam is far greener than most people realize. An institution The first thing to think about in regard to boilers and green technology is just how widespread its use is.

Feb 23, 2024 | ejso.com | Steven Taylor |Liudmila L. Kodach |Jolanda van Dieren |Ignace de Hingh |Steven L. Taylor |Bas PL Wijnhoven | +3 more

Background: The clinical significance of tumour positive peritoneal cytology (CYT+) in patients with gastric cancer (GC) is unclear and therefore managed differently worldwide. The objectives of this study using nationwide data from the Netherlands Cancer Registry (NCR) were 1. to assess the frequency of cytological analysis at staging laparoscopy in GC patients, 2. to estimate the prevalence of CYT+ GC and 3.

Feb 22, 2024 | erj.ersjournals.com | Steven Taylor |Luke Hoffman |James Chalmers

FootnotesConflict of interest: J.D. Chalmers has received research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Gilead Sciences, Grifols, Novartis, Insmed and Trudell, and received consultancy or speaker fees from Antabio, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Insmed, Janssen, Novartis, Pfizer, Trudell and Zambon. The remaining authors have no potential conflicts of interest to disclose.